投資会社は 7万株以上のファイザー株を買い 価値は220万ドル 会社の評価はEPSの予想を上回る Investment firms purchase over 70,000 Pfizer shares, valued at $2.2M, as the company beats EPS estimates.

投資会社はファイザー社の株式を購入しており、最近の購入額は合計70,000株以上、約220万ドル相当です。 Investment firms have been buying Pfizer Inc. stock, with recent purchases totaling over 70,000 shares valued at about $2.2 million. ppfizer は,年収が7.8%減少したにもかかわらず,0.92ドルでEPSを突破したと報告している. Pfizer reported EPS of $0.92, beating estimates by $0.25, though revenue was down 7.8% year-over-year. 同社は医薬品やワクチンを提供し,最近COVID-19製品を導入した. The company offers medicines and vaccines and recently introduced COVID-19 products. ppfizerは134.23億円の市場キャップを備えており,合意の目標価格は29.17ドルである. Pfizer has a market cap of $134.23 billion and a consensus target price of $29.17.